InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

Revenues during 2023 reached NIS 356 million, alongside an Adjusted EBITDA1 of NIS 61 million , as compared to an Adjusted EBITDA of NIS 51 million in our preliminary results.



The Company’s...

Related Keywords

Ukraine ,Israel ,Gaza ,Israel General ,Germany ,United States ,America ,Israeli ,Alexander Rabinovitch ,Intercure Ltd ,Company Southern Facility ,Nasdaq ,Exchange Commission ,Israel Defense ,New Israeli Shekels ,Southern Facility ,Israel Defense Forces ,Israeli Law ,Intercure Noted ,Good Manufacturing Practices ,Annual Report ,Markets ,